From January 19, 2026, Ph.D Juris Hmeļņickis will take up the position of Chairman of the Board of the Latvian pharmaceutical manufacturer AS Olpha.

Latvian pharmaceutical manufacturer JSC Olpha continues to expand its presence in international markets, starting its first deliveries to Latin American countries.

Electronic shelf labels have already been introduced in five Mēness aptieka pharmacies with a high customer flow in Riga and Jelgava.

“Klīnika EGV” has received the “Investment in Latvia’s human capital” special award within the TOP 500+ ranking of Latvia`s strongest companies

On November 12 this year, 5,141 people received a free hepatitis C antibody test (anti-HCV) as part of the social campaign “Detect. Act!” organized by the Digestive Diseases Association and “Centrālā laboratorija”.

To support the pharmaceutical production outlined in its development plans, Olpha has purchased and installed new manufacturing equipment with a total investment of EUR 4.4 million.

The informative campaign "How much is too much?" raises awareness about type 2 diabetes prevention.

At the end of November, Centrālā laboratorija, Veselības centru apvienība, and Mēness aptieka, in collaboration with Delfi TV, are launching a new programme dedicated to health and medicine - “Practically healthy”.

“Veselības centru apvienība” provided more than 1.5 million visits to 375,000 unique patients in 2024

The Baltics’ most advanced medical laboratory, Centrālā laboratorija, invested EUR 2.13 million last year to enhance the quality and accessibility of its laboratory services.

Several healthcare professionals from AB City group companies were honored with state awards at a formal ceremony for their significant contributions to the sector.